Collegium Pharmaceutical, Inc. Debt Conversion, Original Debt, Amount
Collegium Pharmaceutical, Inc. (COLL) reported Debt Conversion, Original Debt, Amount of $5.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2018-03-07
- Collegium Pharmaceutical, Inc. debt conversion, original debt, amount for the quarter ending 2015-12-31 was $0.00.
- Collegium Pharmaceutical, Inc. debt conversion, original debt, amount for the quarter ending 2015-09-30 was $0.00.
- Collegium Pharmaceutical, Inc. debt conversion, original debt, amount for the quarter ending 2015-06-30 was $0.00.
- Collegium Pharmaceutical, Inc. debt conversion, original debt, amount for the quarter ending 2015-03-31 was $5.00M.
- Collegium Pharmaceutical, Inc. debt conversion, original debt, amount for fiscal 2015 was $5.00M, a 51.52% increase from fiscal 2014.
- Collegium Pharmaceutical, Inc. debt conversion, original debt, amount for fiscal 2014 was $3.30M, a 12.78% increase from fiscal 2013.
- Collegium Pharmaceutical, Inc. debt conversion, original debt, amount for fiscal 2013 was $2.93M.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month | Debt Conversion, Original Debt, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $0.00 derived: sum of 2 quarters · filed 2018-03-07 | $0.00 derived: sum of 3 quarters · filed 2018-03-07 | $5.00M 10-K · filed 2018-03-07 | $24.57M 10-K · filed 2016-03-18 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $5.00M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $5.00M 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | $5.00M 10-Q · filed 2016-05-11 | ||||
| 2014-12-31 | $3.30M 10-K · filed 2016-03-18 | ||||
| 2013-12-31 | $2.93M 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |